[1]
D. Setiawan, R. R. Tjandrawinata, Lianawati, Galar Sigit Prasuma, Andi Nurul Annisa, and Sidartawan Soegondo, “The Use of Inlacin in Type 2 Diabetes Mellitus Management in Indonesia: A Cost-Effectiveness Analysis of Real-World Evidence”, Indonesian J Pharm, Feb. 2025.